Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis

Fredrik Schjesvold; Paul G. Richardson; Thierry Facon; Adrian Alegre; Andrew Spencer; Artur Jurczyszyn; Kazutaka Sunami; Laurent Frenzel; Chang Ki Min; Sophie Guillonneau; Peggy L. Lin; Solenn Le-Guennec; Frank Campana; Helgi van de Velde; Samira Bensfia; Sara Bringhen

doi:10.3324/haematol.2020.253450

Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis

Fredrik Schjesvold, Paul G. Richardson, Thierry Facon, Adrian Alegre, Andrew Spencer, Artur Jurczyszyn, Kazutaka Sunami, Laurent Frenzel, Chang Ki Min, Sophie Guillonneau, Peggy L. Lin, Solenn Le-Guennec, Frank Campana, Helgi van de Velde, Samira Bensfia, Sara Bringhen

Research output: Contribution to journal › Letter › peer-review

29 Scopus citations

Original language	English
Pages (from-to)	1182-1187
Number of pages	6
Journal	Haematologica
Volume	106
Issue number	4
DOIs	https://doi.org/10.3324/haematol.2020.253450
State	Published - Apr 2021

Bibliographical note

Funding Information:
Acknowledgments: the authors thank the participating patients and their families, and the study centers and investigators for their contributions to the study. We specially thank Professor Michel Attal from the Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France, a co-primary investigator of the ICARIA-MM study, for reviewing this manuscript. We thank Medha Sasane, Wahidullah Noori and Denise Bury for their contributions to the Patient Reported Outcomes and Health-Related Quality of Life data collection and interpretation. Medical writing support was provided by Camile Semighini Grubor, PhD of Elevate Medical Affairs, contracted by Sanofi Genzyme for publication support services. Funding: the ICARIA-MM study was sponsored by Sanofi.

Access to Document

10.3324/haematol.2020.253450

Cite this

Schjesvold, F., Richardson, P. G., Facon, T., Alegre, A., Spencer, A., Jurczyszyn, A., Sunami, K., Frenzel, L., Min, C. K., Guillonneau, S., Lin, P. L., Le-Guennec, S., Campana, F., van de Velde, H., Bensfia, S., & Bringhen, S. (2021). Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis. Haematologica, 106(4), 1182-1187. https://doi.org/10.3324/haematol.2020.253450

@article{ee34619c1ca44a618372661be8b2b612,

title = "Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis",

author = "Fredrik Schjesvold and Richardson, \{Paul G.\} and Thierry Facon and Adrian Alegre and Andrew Spencer and Artur Jurczyszyn and Kazutaka Sunami and Laurent Frenzel and Min, \{Chang Ki\} and Sophie Guillonneau and Lin, \{Peggy L.\} and Solenn Le-Guennec and Frank Campana and \{van de Velde\}, Helgi and Samira Bensfia and Sara Bringhen",

note = "Funding Information: Acknowledgments: the authors thank the participating patients and their families, and the study centers and investigators for their contributions to the study. We specially thank Professor Michel Attal from the Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France, a co-primary investigator of the ICARIA-MM study, for reviewing this manuscript. We thank Medha Sasane, Wahidullah Noori and Denise Bury for their contributions to the Patient Reported Outcomes and Health-Related Quality of Life data collection and interpretation. Medical writing support was provided by Camile Semighini Grubor, PhD of Elevate Medical Affairs, contracted by Sanofi Genzyme for publication support services. Funding: the ICARIA-MM study was sponsored by Sanofi.",

year = "2021",

month = apr,

doi = "10.3324/haematol.2020.253450",

language = "English",

volume = "106",

pages = "1182--1187",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "4",

}

Schjesvold, F, Richardson, PG, Facon, T, Alegre, A, Spencer, A, Jurczyszyn, A, Sunami, K, Frenzel, L, Min, CK, Guillonneau, S, Lin, PL, Le-Guennec, S, Campana, F, van de Velde, H, Bensfia, S & Bringhen, S 2021, 'Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis', Haematologica, vol. 106, no. 4, pp. 1182-1187. https://doi.org/10.3324/haematol.2020.253450

TY - JOUR

T1 - Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma

T2 - ICARIA-MM subgroup analysis

AU - Schjesvold, Fredrik

AU - Richardson, Paul G.

AU - Facon, Thierry

AU - Alegre, Adrian

AU - Spencer, Andrew

AU - Jurczyszyn, Artur

AU - Sunami, Kazutaka

AU - Frenzel, Laurent

AU - Min, Chang Ki

AU - Guillonneau, Sophie

AU - Lin, Peggy L.

AU - Le-Guennec, Solenn

AU - Campana, Frank

AU - van de Velde, Helgi

AU - Bensfia, Samira

AU - Bringhen, Sara

N1 - Funding Information: Acknowledgments: the authors thank the participating patients and their families, and the study centers and investigators for their contributions to the study. We specially thank Professor Michel Attal from the Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France, a co-primary investigator of the ICARIA-MM study, for reviewing this manuscript. We thank Medha Sasane, Wahidullah Noori and Denise Bury for their contributions to the Patient Reported Outcomes and Health-Related Quality of Life data collection and interpretation. Medical writing support was provided by Camile Semighini Grubor, PhD of Elevate Medical Affairs, contracted by Sanofi Genzyme for publication support services. Funding: the ICARIA-MM study was sponsored by Sanofi.

PY - 2021/4

Y1 - 2021/4

UR - https://www.scopus.com/pages/publications/85103683756

U2 - 10.3324/haematol.2020.253450

DO - 10.3324/haematol.2020.253450

M3 - Letter

C2 - 32586908

AN - SCOPUS:85103683756

SN - 0390-6078

VL - 106

SP - 1182

EP - 1187

JO - Haematologica

JF - Haematologica

IS - 4

ER -

Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis

Bibliographical note

Access to Document

Other files and links

Cite this